Condition: Atrial Fibrillation (AF) · Ventricular Tachycardia (VT) · Sponsor: Beijing Anzhen Hospital
This is a prospective, non-randomized, multicenter observational registry study designed to systematically evaluate the long-term efficacy and safety of catheter ablation for treating atrial fibrillation (AF) and ventricular tachycardia (VT) in Chinese patients.
This description comes directly from the study's public registry record.
Deyong Long, MD · +86 (010) 84005361 · dragon2008@vip.sina.com
Deyong Long · +86 (010) 84005361 · dragon2008@vip.sina.com
Always discuss trial participation with your own doctor first.
| No. 2 Anzhen Rd, Chaoyang District, 100029 | Beijing, Beijing Municipality, China | Recruiting |
| Beijing Anzhen Hospital, Capital Medical University | Beijing, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07024927